Safety syringes and needles to support covid-19 response.

Ended Definitive Contract Awarded Last action

Contract number
W911SR20C0048
Awardee
Awarding agency
Obligated
$8,213,804

Award facts

Opportunity
Contract value 100% obligated
$8,213,804.45 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 16 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Northfield, IL 60093, USA
Legislative mandates
National interest action
Coronavirus COVID-19

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00004 -$1,106,028
Supplemental Agreement for work within scope P00003 · 1ML safety needle/syringe 25G 1" $0
Supplemental Agreement for work within scope P00002 · Safety needles/syringes in support of covid-19 vaccine effort under operation warp speed. $3,059,832
Supplemental Agreement for work within scope P00001 · Safety needles/syringes to support covid-19 vaccine effort under operation warp speed. $0
Original award $6,260,000

About this award

This definitive contract awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Medline Industries, LP provides for the delivery of safety syringes and needles in support of COVID-19 response efforts. The $8.2 million firm-fixed price contract calls for Medline to supply up to 500 million FDA-approved combination needle and syringe units from its Winnetka, Illinois facility between August 2020 and August 2021. This award fulfills requirements set forth in the Needles and Syringes solicitation seeking proposals for 270 million 1ml syringes and 230 million 3ml syringes for distribution to seven designated cities by the Department of Health and Human Services' Assistant Secretary for Preparedness and Response and Biomedical Advanced Research and Development Authority to aid in nationwide COVID-19 vaccination, testing and treatment. There was no set-aside designation for this competitively awarded contract supporting the Defense Department's medical countermeasures programs.

Quick answers

Who was awarded contract W911SR20C0048?

W911SR20C0048 was awarded to Medline Industries, LP by ACC Aberdeen Proving Ground (Army Contracting Command) on August 3, 2020.

How much is contract W911SR20C0048 worth?

The government has obligated $8,213,804 on W911SR20C0048.

Which agency awarded contract W911SR20C0048?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR20C0048, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911SR20C0048 competed?

The extent of competition for W911SR20C0048 was full and open competition. The government received 16 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award